Takeda, and strengthening the acquisition oncology rice Intellikine company in about 15 billion yen

Takeda Pharmaceutical Company Limited and the US Intellikine, Inc. (Headquarters: La Jolla, California, USA) April 21, Takeda America Holdings (a wholly owned subsidiary of Takeda) announced that it has agreed that the acquisition of Intellikine, Inc..The purchase price is 190 million dollars (about 15 billion yen).In addition, the future, there is a possibility to pay a maximum of $ 120 million (about 9.3 billion yen) as a development milestone.Intellikine, Inc. has conducted a study of the cancer field, Takeda is available through the company’s acquisition, promote the further strengthening of the cancer area.